Neosensory is a technology company.
Neosensory has raised $10.0M across 1 funding round.
Neosensory has raised $10.0M in total across 1 funding round.
Neosensory has raised $10.0M in total across 1 funding round.
Neosensory's investors include Endeavor Venture Funds, New Age Ventures, Next Coast Ventures, Redpoint Ventures, S3 Ventures, Tensility Venture Partners, True Wealth Ventures.
Neosensory is a neuroscience-driven technology company that develops wearable devices designed to create new sensory experiences by converting data streams—such as sound—into patterns of vibrations on the skin. Its flagship product, the Buzz wristband, serves primarily people with hearing loss or tinnitus by providing an alternative sensory channel to perceive sounds through haptic feedback. This technology addresses the limitations and costs of traditional hearing aids and cochlear implants, enabling users to "listen" via their skin. Neosensory has demonstrated strong growth momentum, recently securing $10 million in Series A funding to accelerate product release and global expansion[1][3][6].
Neosensory was co-founded by neuroscientists David Eagleman and Scott Novich, who began their research in 2013 while Novich was a PhD student and Eagleman a professor. Their initial idea was to create a general sensory substitution device, the VEST, which gained significant attention after Eagleman’s TED talk on creating new human senses. Supported by True Ventures, the technology was spun out of the lab into an independent company in 2015. Early pivotal moments include the development of the wristband form factor, which miniaturized the technology for consumer use, and the successful demonstration that users with severe hearing loss could interpret sound through skin vibrations[1][2][6].
Neosensory rides the wave of growing interest in brain-machine interfaces and sensory augmentation technologies. The timing is favorable due to advances in wearable tech, neuroscience, and haptic feedback, combined with increasing demand for accessible hearing solutions. Market forces such as the rising prevalence of hearing loss and the limitations of existing devices create a strong need for innovative alternatives. Neosensory’s work influences the broader ecosystem by pioneering non-invasive sensory substitution, potentially expanding human perception and inspiring further research and product development in neurotechnology and assistive devices[1][2][6].
Looking ahead, Neosensory is poised to expand its product line and refine its algorithms to address more nuanced auditory challenges, such as high-frequency hearing loss and tinnitus treatment through bimodal stimulation. Trends in personalized healthcare, wearable neurotechnology, and sensory augmentation will shape its journey. As the company scales globally, its influence may extend beyond hearing assistance to broader applications of sensory substitution, potentially redefining how humans interact with data and their environment. Neosensory’s vision of creating new senses aligns with a future where technology fundamentally expands human perception[1][6].
Neosensory has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 1, 2018 | $10.0M Series A | Endeavor Venture Funds, New Age Ventures, Next Coast Ventures, Redpoint Ventures, S3 Ventures, Tensility Venture Partners, True Wealth Ventures |